BIOGEN INC. (BIIB) Shareholder Equity
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $896.70M; Treasury Stock, ValueUSD $2.98B.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $863.10M; Treasury Stock, ValueUSD $2.98B.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $797.70M; Treasury Stock, ValueUSD $2.98B.
- 2025-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $714.00M; Treasury Stock, ValueUSD $2.98B.
BIOGEN INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Preferred Stock, Value, Outstanding USD | Common Stock, Value, Outstanding USD | Treasury Stock, Common, Shares shares | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Retired, Cost Method, Amount USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Noncontrolling Interest, Increase from Business Combination USD | Noncontrolling Interest, Decrease from Deconsolidation USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $0.00 | $100.00K | $896.70M | $2.98B | $-140.20M | $20.87B | $18.65B | (m) | (m) | (m) | (m) | 3 month · $88.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $100.00K | $863.10M | $2.98B | $-182.00M | $20.55B | $18.26B | $0.00 | $100.00K | 23.80M | 12 month · $303.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $100.00K | $797.70M | $2.98B | $-214.80M | $20.60B | $18.21B | (m) | (m) | (m) | (m) | 3 month · $78.40M 9 month · $240.60M | 3 month · 0.00 9 month · 0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $100.00K | $714.00M | $2.98B | $-238.10M | $20.14B | $17.63B | (m) | (m) | (m) | (m) | 3 month · $78.10M 6 month · $162.20M | 3 month · 0.00 6 month · 0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $100.00K | $629.90M | $2.98B | $-174.50M | $19.50B | $16.98B | (m) | (m) | (m) | (m) | 3 month · $84.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $100.00K | $569.40M | $2.98B | $-136.20M | $19.26B | $16.72B | $0.00 | $100.00K | 23.80M | 12 month · $301.50M | (m) | 12 month · 0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $100.00K | $488.50M | $2.98B | $-145.70M | $18.99B | $16.36B | (m) | (m) | (m) | (m) | 3 month · $75.00M | 3 month · 0.00 9 month · 0.00 | 3 month · $8.10M 9 month · $5.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $100.00K | $407.50M | $2.98B | $-146.00M | $18.60B | $15.89B | (m) | (m) | (m) | (m) | 3 month · $72.90M | 3 month · 0.00 6 month · 0.00 | 3 month · $-2.20M 6 month · $-2.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $100.00K | $329.50M | $2.98B | $-160.50M | $18.02B | $15.21B | (m) | (m) | (m) | (m) | 3 month · $76.10M | (m) | 3 month · $-700.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $100.00K | $302.50M | $2.98B | $-153.70M | $17.63B | $14.80B | $0.00 | $100.00K | 23.80M | 12 month · $274.40M | (m) | 12 month · 0.00 | (m) | (m) | (m) | (m) | $14.80B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $100.00K | $242.20M | $2.98B | $-159.30M | $17.38B | $14.48B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $12.60M 9 month · $-4.40M | (m) | (m) | (m) | $14.48B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $100.00K | $170.70M | $2.98B | $-172.80M | $17.45B | $14.46B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-2.30M 6 month · $-17.00M | (m) | (m) | (m) | $14.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $100.00K | $91.20M | $2.98B | $-172.00M | $16.85B | $13.79B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-14.70M | (m) | (m) | (m) | $13.80B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $100.00K | $73.30M | $2.98B | $-164.90M | $16.47B | $13.39B | $0.00 | $100.00K | 23.80M | (m) | (m) | (m) | 12 month · $145.20M | (m) | (m) | (m) | $13.40B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 23.80M |
| 2022-09-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-163.60M | $15.92B | $12.77B | (m) | (m) | (m) | (m) | (m) | 3 month · 1.20M 9 month · 3.60M | 9 month · $-97.30M | (m) | (m) | (m) | $12.78B | 3 month · $250.00M 9 month · $750.00M | 3 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-110.40M | $14.96B | $11.86B | (m) | (m) | (m) | (m) | (m) | 3 month · 2.40M 6 month · 2.40M | 6 month · $-34.50M | (m) | (m) | (m) | $11.87B | 3 month · $500.00M 6 month · $500.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $100.00K | $119.00M | $2.98B | $-115.20M | $14.22B | $11.22B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-16.90M | (m) | (m) | (m) | $11.24B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $100.00K | $68.20M | $2.98B | $-106.70M | $13.91B | $10.96B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-58.20M | (m) | (m) | (m) | $10.90B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 23.80M |
| 2021-09-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-136.60M | $13.54B | $10.88B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $63.00M | (m) | (m) | (m) | $10.43B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-171.80M | $13.90B | $11.21B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $49.00M | (m) | (m) | (m) | $10.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-174.30M | $13.83B | $10.66B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $21.40M | (m) | (m) | (m) | $10.68B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-299.00M | $13.98B | $10.69B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $18.20M | (m) | (m) | (m) | $10.70B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 23.80M |
| 2020-09-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-225.50M | $13.96B | $10.74B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $-35.90M | (m) | (m) | (m) | $10.76B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-181.00M | $14.47B | $11.29B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $-42.50M | (m) | (m) | (m) | $11.31B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $100.00K | $100.00K | $2.98B | $-149.30M | $15.67B | $12.54B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-14.80M | (m) | (m) | (m) | $12.55B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-135.20M | $16.46B | $13.34B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $125.60M | (m) | (m) | (m) | $13.34B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 23.80M |
| 2019-09-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-92.30M | $17.07B | $13.99B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $-85.60M | (m) | (m) | (m) | $14.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-252.90M | $16.18B | $12.95B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $-48.50M | (m) | (m) | (m) | $12.95B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-219.80M | $17.03B | $13.82B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-16.70M | (m) | (m) | (m) | $13.83B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-240.40M | $16.26B | $13.03B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $47.00M | (m) | (m) | (m) | $13.04B | 12 month · $3.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 23.80M |
| 2018-09-30 | $0.00 | $100.00K | $47.80M | $2.98B | $-248.30M | $16.94B | $13.76B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $56.80M | (m) | (m) | (m) | $13.77B | (m) | (m) | (m) | 3 month · $2.00M 9 month · $13.10M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $100.00K | $0.00 | $2.98B | $-261.60M | $15.50B | $12.25B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $48.10M | (m) | (m) | (m) | $12.26B | (m) | (m) | (m) | 3 month · $11.10M 6 month · $11.10M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-303.90M | $17.33B | $14.04B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $37.40M | (m) | (m) | (m) | $14.05B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $-316.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $100.00K | $97.80M | $2.98B | $-318.40M | $15.81B | $12.60B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $44.20M | (m) | (m) | (m) | $12.61B | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | 23.80M |
| 2017-09-30 | $0.00 | $100.00K | $59.20M | $2.98B | $-329.40M | $16.11B | $12.85B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $15.30M | (m) | (m) | (m) | $12.86B | (m) | (m) | (m) | 3 month · $0.00 9 month · $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $100.00K | $19.30M | $2.98B | $-338.80M | $14.88B | $11.57B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $-3.50M | (m) | (m) | (m) | $11.59B | (m) | (m) | (m) | 3 month · $0.00 6 month · $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $100.00K | $0.00 | $2.98B | $-325.20M | $14.78B | $11.47B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-6.30M | (m) | (m) | (m) | $11.48B | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $100.00K | $0.00 | $2.61B | $-319.90M | $15.07B | $12.13B | (m) | (m) | (m) | (m) | (m) | 12 month · 3.30M | 12 month · $-3.40M | (m) | (m) | (m) | $12.14B | 12 month · $1.00B | 12 month · $0.00 | (m) | 12 month · $600.00K | 12 month · $7.50M | (m) | (m) | 12 month · $600.00K | 22.60M |
| 2016-09-30 | $0.00 | $100.00K | $0.00 | $2.61B | $-300.90M | $15.03B | $12.11B | (m) | (m) | (m) | (m) | (m) | 9 month · 1.10M | 9 month · $1.30M | (m) | (m) | (m) | $12.12B | (m) | (m) | (m) | 3 month · $0.00 9 month · $900.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $0.00 | $100.00K | $69.10M | $2.61B | $-282.80M | $14.23B | $11.40B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $-4.00M | (m) | (m) | (m) | $11.40B | (m) | (m) | (m) | 3 month · $0.00 6 month · $900.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $0.00 | $100.00K | $18.40M | $2.61B | $-259.30M | $13.18B | $10.33B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-8.70M | (m) | (m) | (m) | $10.33B | (m) | (m) | (m) | 3 month · $900.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $100.00K | $0.00 | $2.61B | $-224.00M | $12.21B | $9.37B | (m) | (m) | (m) | (m) | (m) | 12 month · 16.80M | 12 month · $-171.00M | (m) | (m) | (m) | $9.37B | 12 month · $5.00B | 12 month · $0.00 | (m) | 12 month · $10.90M | (m) | (m) | (m) | 12 month · $69.00M | 22.60M |
| 2015-09-30 | $0.00 | $124.00K | $1.34B | $2.61B | $-157.40M | $12.00B | $10.57B | (m) | (m) | (m) | (m) | (m) | 9 month · 9.70M | 9 month · $-117.70M | (m) | (m) | (m) | $10.57B | (m) | (m) | (m) | 3 month · $200.00K 9 month · $100.00K | (m) | 9 month · $144.40M | (m) | (m) | (m) |
| 2015-06-30 | $0.00 | $129.00K | $4.25B | $2.61B | $-101.00M | $11.03B | $12.57B | (m) | (m) | (m) | (m) | (m) | 6 month · 100.00K | 6 month · $-74.80M | (m) | (m) | (m) | $12.57B | (m) | (m) | (m) | 3 month · $0.00 6 month · $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $0.00 | $129.00K | $4.24B | $2.61B | $-70.50M | $10.11B | $11.67B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-34.70M | (m) | (m) | (m) | $11.67B | (m) | (m) | (m) | 3 month · $0.00 | (m) | 3 month · $46.30M | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | $100.00K | $4.20B | $2.61B | $-59.50M | $9.28B | $10.81B | (m) | (m) | (m) | (m) | (m) | 12 month · 2.90M | 12 month · $-12.70M | (m) | (m) | (m) | $10.81B | 12 month · $886.80M | (m) | (m) | 12 month · $6.70M | (m) | (m) | (m) | 12 month · $93.00M | 22.60M |
| 2014-09-30 | $0.00 | $129.00K | $4.15B | $2.08B | $-38.00M | $8.40B | $10.43B | (m) | (m) | (m) | (m) | (m) | 9 month · 1.20M | 9 month · $800.00K | (m) | (m) | (m) | $10.43B | (m) | (m) | (m) | 3 month · $0.00 9 month · $4.00M | 3 month · $0.00 9 month · $0.00 | 9 month · $126.40M | (m) | (m) | (m) |
| 2014-06-30 | $0.00 | $128.00K | $4.11B | $2.06B | $-26.70M | $7.54B | $9.57B | (m) | (m) | (m) | (m) | (m) | 6 month · 1.20M | 6 month · $3.50M | (m) | (m) | (m) | $9.56B | (m) | (m) | (m) | 3 month · $0.00 6 month · $4.00M | 3 month · $0.00 6 month · $0.00 | 6 month · $82.40M | (m) | (m) | (m) |
| 2014-03-31 | $0.00 | $128.00K | $4.05B | $1.72B | $-22.40M | $6.83B | $9.14B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $4.20M | (m) | (m) | (m) | $9.14B | (m) | (m) | (m) | 3 month · $4.00M | 3 month · $0.00 | 3 month · $31.10M | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | $128.00K | $4.02B | $1.72B | $-27.70M | $6.35B | $8.62B | (m) | (m) | (m) | (m) | (m) | 12 month · 2.00M | 12 month · $3.30M | (m) | (m) | (m) | $8.62B | 12 month · $400.30M | (m) | (m) | (m) | 12 month · $1.70M | (m) | (m) | 12 month · $45.90M | 19.64B |
| 2013-09-30 | $0.00 | $128.00K | $3.99B | $1.72B | $-29.30M | $5.89B | $8.13B | (m) | (m) | (m) | (m) | (m) | 3 month · 1.70M 9 month · 2.00M | 9 month · $3.50M | (m) | (m) | (m) | $8.13B | (m) | (m) | (m) | 3 month · $0.00 9 month · $0.00 | 3 month · $0.00 9 month · $1.70M | 9 month · $132.90M | (m) | (m) | (m) |
| 2013-06-30 | $0.00 | $128.00K | $3.92B | $1.37B | $-55.10M | $5.40B | $7.90B | (m) | (m) | (m) | (m) | (m) | 6 month · 300.00K | 6 month · $-3.70M | (m) | (m) | (m) | $7.90B | (m) | (m) | (m) | 3 month · $0.00 6 month · $0.00 | 3 month · $0.00 6 month · $1.70M | 6 month · $63.50M | (m) | (m) | (m) |
| 2013-03-31 | $0.00 | $128.00K | $3.86B | $1.37B | $-68.00M | $4.91B | $7.34B | (m) | (m) | (m) | (m) | (m) | 3 month · 300.00K | 3 month · $-3.70M | (m) | (m) | (m) | $7.34B | (m) | (m) | (m) | 3 month · $0.00 | 3 month · $1.70M | (m) | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | $127.00K | $3.85B | $1.32B | $-55.30M | $4.49B | $6.96B | (m) | (m) | (m) | (m) | (m) | 12 month · 7.80M | 12 month · $-32.60M | $-27.10M | $4.20M | $21.70M | $6.96B | 12 month · $984.72M | (m) | 12 month · $73.00K | (m) | 12 month · $556.00K | (m) | $-10.70M | 12 month · $49.39M | 17.66B |
| 2012-09-30 | $0.00 | $127.00K | $3.82B | $1.30B | $-51.12M | $4.19B | $6.66B | (m) | (m) | (m) | (m) | (m) | 3 month · 400.00K 9 month · 7.70M | (m) | (m) | (m) | (m) | $6.66B | 3 month · $53.20M 9 month · $963.20M | (m) | (m) | (m) | 3 month · $0.00 9 month · $500.00K | 9 month · $134.00M | (m) | (m) | (m) |
| 2012-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 400.00K | (m) | (m) | (m) | (m) | (m) | 1 month · $53.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $127.00K | $3.83B | $1.30B | $-50.56M | $3.80B | $6.27B | (m) | (m) | (m) | (m) | (m) | 3 month · 3.30M 6 month · 7.30M | (m) | (m) | (m) | (m) | $6.27B | 3 month · $446.80M 6 month · $909.90M | (m) | (m) | (m) | 3 month · $500.00K 6 month · $500.00K | 6 month · $87.40M | (m) | (m) | (m) |
| 2012-03-31 | (m) | $129.00K | $4.22B | $1.30B | $-17.71M | $3.41B | $6.31B | (m) | (m) | (m) | (m) | (m) | 3 month · 4.00M | (m) | (m) | (m) | (m) | $6.31B | (m) | (m) | (m) | (m) | 3 month · $0.00 | 3 month · $32.20M | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | $128.00K | $4.19B | $839.90M | $-26.50M | $3.11B | $6.43B | (m) | (m) | (m) | (m) | (m) | 12 month · 6.00M | 12 month · $-2.40M | $-50.30M | $0.00 | $9.00M | $6.43B | 12 month · $497.98M | (m) | (m) | (m) | (m) | (m) | $32.80M | 12 month · $50.38M | 13.52B |
| 2011-09-30 | (m) | $128.00K | $4.14B | $728.50M | $7.57M | $2.81B | $6.23B | (m) | (m) | (m) | (m) | (m) | 9 month · 5.00M | (m) | (m) | (m) | (m) | $6.23B | 9 month · $386.60M | (m) | (m) | (m) | 3 month · $0.00 9 month · $0.00 | 9 month · $299.50M | (m) | (m) | (m) |
| 2011-06-30 | $0.00 | $127.00K | $4.22B | $728.50M | $25.71M | $2.45B | $6.06B | (m) | (m) | (m) | (m) | (m) | 6 month · 5.00M | (m) | (m) | (m) | (m) | $5.98B | 6 month · $386.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-21 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $75.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $0.00 | $125.00K | $3.98B | $537.22M | $-992.00K | $2.17B | $5.67B | (m) | (m) | (m) | (m) | (m) | 3 month · 2.80M | (m) | (m) | (m) | (m) | $5.60B | 3 month · $195.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $124.00K | $3.90B | $349.59M | $-21.60M | $1.87B | $5.45B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-24.40M | $12.40M | $200.00K | $5.40B | 12 month · $2.08B | (m) | (m) | (m) | (m) | (m) | $-9.80M | 12 month · $19.31M | 7.66M |
| 2010-09-30 | $0.00 | $124.00K | $3.86B | $462.81M | $-9.16M | $1.65B | $5.07B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.03B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $0.00 | $129.00K | $4.28B | $488.98M | $-28.42M | $1.41B | $5.21B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.17B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | $0.00 | $139.00K | $5.27B | $513.63M | $22.87M | $1.13B | $5.95B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.91B | 3 month · $557.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $0.00 | $144.00K | $5.78B | $679.92M | $50.50M | $1.07B | $6.26B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $35.60M | $11.30M | $2.10M | $6.22B | 12 month · $751.17M | (m) | (m) | (m) | (m) | (m) | $1.50M | 12 month · $-36.83M | 13.64M |
| 2009-09-30 | $0.00 | $149.00K | $6.18B | $438.71M | $37.11M | $781.32M | $6.60B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | $0.00 | $149.00K | $6.14B | $-458.47M | $11.29M | $516.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.25B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $0.00 | $149.00K | $6.07B | $527.10M | $-11.11M | $270.18M | $5.83B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.81B | 12 month · $-738.94M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $29.84M | 9.21M |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $5.55B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $67.23M | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $7.16B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |